Ghanbari; Hossein

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ghanbari; Hossein.The latest application filed is for "recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patients".

Company Profile

6.5.11

Ghanbari; Hossein - Tehran N/A IR
Ghanbari; Hossein - Potomac MD
Ghanbari; Hossein - Gaithersburg MD
Ghanbari; Hossein - Gathersburg MD
Ghanbari; Hossein - Beaconsfield CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fibrous nerve conduit for promoting nerve regeneration Grant 11,369,717 - Ghanbari , et al. June 28, 2	2022-06-28
Recovery Of Aspartyl (asparaginyl) Beta Hydroxylase (haah) From An Exosomal Fraction Of Human Sera From Cancer Patients App 20210148915 - Semenuk; Mark ; et al.	2021-05-20
Antibody-Drug Conjugates Targeted at Human Aspartyl-(Asparaginyl)-B-Hydroxylase (HAAH) App 20200390902 - Ghanbari; Hossein ; et al.	2020-12-17
Fibrous Nerve Conduit For Promoting Nerve Regeneration App 20200384157 - Ghanbari; Hossein ; et al.	2020-12-10
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase Grant 10,702,591 - Biswas , et al.	2020-07-07
Treatment for chemotherapy-induced peripheral neuropathy Grant 10,525,044 - Ghanbari , et al. J	2020-01-07
HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when Combined App 20190049455 - Ghanbari; Hossein ; et al.	2019-02-14
Treatment for Chemotherapy-induced Peripheral Neuropathy App 20180200236 - Ghanbari; Hossein ; et al.	2018-07-19
Recovery Of Aspartyl (asparaginyl) Beta Hydroxylase (haah) From An Exosomal Fraction Of Human Sera From Cancer Patients App 20180203013 - Semenuk; Mark ; et al.	2018-07-19
Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-Beta-Hydroxylase App 20180092969 - Biswas; Biswajit ; et al.	2018-04-05
Immune System Enhancing Immunotherapy For The Treatment Of Cancer App 20180036424 - GHANBARI; HOSSEIN	2018-02-08
Recovery Of Aspartyl (asparaginyl) Beta Hydroxylase (haah) From An Exosomal Fraction Of Human Sera From Cancer Patients App 20160077098 - Semenuk; Mark ; et al.	2016-03-17
Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions Grant 6,130,221 - Averback , et al. October 10, 2	2000-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.